Endocrine Disruptors and Prostaglandin Synthesis
Author Information
Author(s): David M. Kristensen, Maria L. Skalkam, Karine Audouze, Laurianne Lesné, Christele Desdoits-Lethimonier, Hanne Frederiksen, Søren Brunak, Niels E. Skakkebæk, Bernard Jégou, Jacob B. Hansen, Steffen Junker, Henrik Leffers
Primary Institution: Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Hypothesis
Can known endocrine-disrupting compounds inhibit the prostaglandin pathway?
Conclusion
The study found that many known endocrine disruptors inhibit the prostaglandin pathway, suggesting a new mechanism of endocrine disruption.
Supporting Evidence
- Many known endocrine disruptors inhibit the prostaglandin pathway in mouse Sertoli cells and human mast cells.
- The inhibition of prostaglandin synthesis was correlated with reduced testosterone production.
- EDCs did not affect the expression of COX enzymes but inhibited their activity.
Takeaway
Some chemicals that disrupt hormones can also stop the body from making important substances called prostaglandins, which help with many body functions.
Methodology
The study used cell-based experiments, mass spectrometry, and organotypic assays to investigate the effects of endocrine disruptors on prostaglandin synthesis.
Limitations
The study primarily focused on specific cell lines and may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website